​​1.	Hakansson AP, Orihuela CJ, Bogaert D. Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. Physiol Rev. 2018 Apr 1;98(2):781–811.  

​2.	Farmacotherapeutisch kompas. Macroliden.  

​3.	Parnham MJ, Haber VE, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: Mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014 Aug;143(2):225–45.  

​4.	Vázquez-Laslop N, Mankin AS. How Macrolide Antibiotics Work. Trends Biochem Sci. 2018 Sep;43(9):668–84.  

​5.	Giudicessi JR, Ackerman MJ, Camilleri M. Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias. Neurogastroenterology & Motility. 2018 Jun 14;30(6).  

​6.	Fyfe C, Grossman TH, Kerstein K, Sutcliffe J. Resistance to Macrolide Antibiotics in Public Health Pathogens. Cold Spring Harb Perspect Med. 2016 Oct;6(10):a025395.  

​7.	Keskin-Arslan E, Erol H, Uysal N, Karadas B, Temiz T, Kaplan YC. Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis. Reproductive Toxicology. 2023 Jan;115:124–46.  

​8.	Zhanel GG, Hartel E, Adam H, Zelenitsky S, Zhanel MA, Golden A, et al. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs. 2016 Dec 1;76(18):1737–57.  

​9.	Buege MJ, Brown JE, Aitken SL. Solithromycin: A novel ketolide antibiotic. American Journal of Health-System Pharmacy. 2017 Jun 15;74(12):875–87.  

​10.	Kricker JA, Page CP, Gardarsson FR, Baldursson O, Gudjonsson T, Parnham MJ. Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development. Pharmacol Rev. 2021 Oct 21;73(4):1404–33.

figuur 1: https://www.gezondheidenwetenschap.be/richtlijnen/acute-luchtweginfecties-bij-volwassenen
figuur 2, geadapteerd uit: https://www-sciencedirect-com.ezproxy.leidenuniv.nl/science/article/pii/S0968000418301282?via%3Dihub
figuur 3: Mechanism of Action of Protein synthesis inhibitor (Macrolides) (Blondeau, 2004). Geupload door Dr. Umar Farooq Gohar.
